Regulus Therapeutics Inc. (RGLS): Price and Financial Metrics
RGLS Price/Volume Stats
| Current price | $8.16 | 52-week high | $8.35 |
| Prev. close | $8.14 | 52-week low | $0.83 |
| Day low | $8.07 | Volume | 9,342,400 |
| Day high | $8.18 | Avg. volume | 1,649,548 |
| 50-day MA | $6.65 | Dividend yield | N/A |
| 200-day MA | $2.76 | Market Cap | 564.95M |
RGLS Stock Price Chart Interactive Chart >
Regulus Therapeutics Inc. (RGLS) Company Bio
Regulus Therapeutics is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. The company was founded in 2007 and is based in San Diego, California.
RGLS Price Returns
| 1-mo | 2.64% |
| 3-mo | 384.27% |
| 6-mo | 406.83% |
| 1-year | N/A |
| 3-year | 305.97% |
| 5-year | N/A |
| YTD | 416.46% |
| 2024 | 23.44% |
| 2023 | -6.57% |
| 2022 | -56.51% |
| 2021 | -76.67% |
| 2020 | 51.69% |
Continue Researching RGLS
Here are a few links from around the web to help you further your research on Regulus Therapeutics Inc's stock as an investment opportunity:Regulus Therapeutics Inc (RGLS) Stock Price | Nasdaq
Regulus Therapeutics Inc (RGLS) Stock Quote, History and News - Yahoo Finance
Regulus Therapeutics Inc (RGLS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...